Malignancy in SARS-CoV2 infection
Study population: all the residents in the Veneto Region who were consecutively tested for SARS-CoV-2 infection between February 22nd and April 1st, 2020.
· demographics (age, sex)
· history of malignant disease (prevalent diagnosis of malignant cancer, cancer site, interval between diagnosis of cancer and testing for SARS-CoV-2 infection)
· clinical outcomes of SARS-CoV-2 infection (admission to hospital; admission to Intensive Care Unit; death)